Pro-Dex (PDEX) Competitors $44.35 +0.02 (+0.05%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$44.08 -0.27 (-0.60%) As of 08:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends PDEX vs. KIDS, TMCI, SMLR, NNOX, CLPT, TCMD, DCTH, ZIMV, CVRX, and NPCEShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), Nano-X Imaging (NNOX), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Delcath Systems (DCTH), ZimVie (ZIMV), CVRx (CVRX), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry. Pro-Dex vs. OrthoPediatrics Treace Medical Concepts Semler Scientific Nano-X Imaging ClearPoint Neuro Tactile Systems Technology Delcath Systems ZimVie CVRx NeuroPace Pro-Dex (NASDAQ:PDEX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations. Is PDEX or KIDS more profitable? Pro-Dex has a net margin of 9.17% compared to OrthoPediatrics' net margin of -15.00%. Pro-Dex's return on equity of 16.74% beat OrthoPediatrics' return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex9.17% 16.74% 9.98% OrthoPediatrics -15.00%-5.78%-4.80% Do analysts rate PDEX or KIDS? Pro-Dex presently has a consensus target price of $52.00, indicating a potential upside of 17.25%. OrthoPediatrics has a consensus target price of $39.00, indicating a potential upside of 43.59%. Given OrthoPediatrics' higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Pro-Dex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00OrthoPediatrics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do institutionals & insiders have more ownership in PDEX or KIDS? 15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, PDEX or KIDS? Pro-Dex has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$53.84M2.69$2.13M$1.5428.80OrthoPediatrics$148.73M4.42-$20.97M-$1.23-22.08 Does the media favor PDEX or KIDS? In the previous week, Pro-Dex had 8 more articles in the media than OrthoPediatrics. MarketBeat recorded 12 mentions for Pro-Dex and 4 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.52 beat Pro-Dex's score of 0.40 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer PDEX or KIDS? OrthoPediatrics received 157 more outperform votes than Pro-Dex when rated by MarketBeat users. Likewise, 64.26% of users gave OrthoPediatrics an outperform vote while only 61.85% of users gave Pro-Dex an outperform vote. CompanyUnderperformOutperformPro-DexOutperform Votes15461.85% Underperform Votes9538.15% OrthoPediatricsOutperform Votes31164.26% Underperform Votes17335.74% Which has more volatility and risk, PDEX or KIDS? Pro-Dex has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. SummaryOrthoPediatrics beats Pro-Dex on 9 of the 17 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$144.55M$4.78B$5.34B$9.11BDividend YieldN/A52.58%5.37%4.00%P/E Ratio28.8013.8156.8413.06Price / Sales2.6958.081,275.3476.04Price / Cash46.3150.8936.6132.89Price / Book4.917.794.874.58Net Income$2.13M$13.87M$118.05M$224.84M7 Day Performance-1.44%2.85%1.47%2.37%1 Month Performance-9.01%10.48%2.54%4.40%1 Year Performance109.99%32.32%25.37%20.10% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex3.4622 of 5 stars$44.35+0.0%$52.00+17.2%+110.0%$144.55M$53.84M28.80140KIDSOrthoPediatrics4.0311 of 5 stars$25.00+2.3%$39.00+56.0%-5.8%$605.40M$189.67M-20.33200Short Interest ↑TMCITreace Medical Concepts0.8977 of 5 stars$8.36+14.5%$8.98+7.5%-32.6%$520.80M$202.86M-8.44250SMLRSemler Scientific1.1592 of 5 stars$52.70+2.6%N/A+47.8%$488.37M$58.94M25.71120Gap UpNNOXNano-X Imaging2.367 of 5 stars$7.39-8.4%$17.50+136.8%+56.9%$426.99M$10.68M-8.69190Gap DownCLPTClearPoint Neuro0.6185 of 5 stars$15.40+4.9%$11.33-26.4%+100.3%$424.81M$30.43M-22.32110Positive NewsTCMDTactile Systems Technology3.5201 of 5 stars$17.20-0.2%$23.00+33.7%+27.5%$412.75M$285.05M26.46980DCTHDelcath Systems3.5967 of 5 stars$12.79+11.4%$21.50+68.1%+261.4%$408.90M$2.07M-9.4760Gap UpZIMVZimVie2.9337 of 5 stars$13.64+1.1%$19.50+43.0%-19.8%$376.45M$451.29M-1.042,700News CoveragePositive NewsCVRXCVRx2.166 of 5 stars$15.04+6.1%$16.67+10.8%-33.6%$364.93M$47.26M-5.57160News CoveragePositive NewsNPCENeuroPace3.4117 of 5 stars$12.11+1.4%$15.00+23.9%-16.2%$361.46M$76.45M-12.11170Analyst ForecastNews Coverage Related Companies and Tools Related Companies KIDS Competitors TMCI Competitors SMLR Competitors NNOX Competitors CLPT Competitors TCMD Competitors DCTH Competitors ZIMV Competitors CVRX Competitors NPCE Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PDEX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.